Log In
Print this Print this

MVA-BN Brachyury

  Manage Alerts
Collapse Summary General Information
Company Bavarian Nordic A/S
DescriptionModified vaccinia Ankara (MVA) vector vaccine against T brachyury
Molecular Target T brachyury
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat advanced cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today